Fresenius Medical Care AG & Co. KGaA – NYSE:FMS
Fresenius Medical Care AG & Co. KGaA stock price today
$24.98
+2.01
+8.75%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 8 hours
Fresenius Medical Care AG & Co. KGaA stock price monthly change
+15.37%
month
Fresenius Medical Care AG & Co. KGaA stock price quarterly change
+15.37%
quarter
Fresenius Medical Care AG & Co. KGaA stock price yearly change
+9.17%
year
Fresenius Medical Care AG & Co. KGaA key metrics
Market Cap | 13.46B |
Enterprise value | 22.76B |
P/E | 9.81 |
EV/Sales | 1.18 |
EV/EBITDA | 7.13 |
Price/Sales | 0.67 |
Price/Book | 0.47 |
PEG ratio | 2.55 |
EPS | 1.65 |
Revenue | 19.47B |
EBITDA | 3.27B |
Income | 483.59M |
Revenue Q/Q | 0.44% |
Revenue Y/Y | -0.40% |
Profit margin | 3.42% |
Oper. margin | 8.02% |
Gross margin | 25.14% |
EBIT margin | 8.02% |
EBITDA margin | 16.82% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeFresenius Medical Care AG & Co. KGaA stock price history
Fresenius Medical Care AG & Co. KGaA stock forecast
Fresenius Medical Care AG & Co. KGaA financial statements
| Jun 2023 | 4.82B | 140.35M | 2.91% |
|---|---|---|---|
| Sep 2023 | 4.93B | 84.35M | 1.71% |
| Dec 2023 | 4.98B | 187.92M | 3.77% |
| Mar 2024 | 4.72B | 70.95M | 1.5% |
| Dec 2023 | 4.98B | 187.92M | 3.77% |
|---|---|---|---|
| Mar 2024 | 4.72B | 70.95M | 1.5% |
| Sep 2025 | 6.54B | 0 | |
| Dec 2025 | 4.36B | 0 |
Analysts Price target
Financials & Ratios estimates
2.87%
Yield TTM
| Payout ratio | 52.99% |
|---|
| 2019 | 3.57% |
|---|---|
| 2020 | 3.51% |
| 2021 | 4.69% |
| 2022 | 8.84% |
| 2023 | 5.83% |
| Jun 2023 | 34960138000 | 20.02B | 57.29% |
|---|---|---|---|
| Sep 2023 | 35634696000 | 20.20B | 56.69% |
| Dec 2023 | 33929808000 | 19.10B | 56.3% |
| Mar 2024 | 34336000000 | 19.20B | 55.93% |
| Jun 2023 | 1.00B | -133.34M | -702.55M |
|---|---|---|---|
| Sep 2023 | 759.75M | -151.10M | -412.33M |
| Dec 2023 | 719.06M | -96.50M | -745.65M |
| Mar 2024 | 127.30M | -68.36M | -289.65M |
Fresenius Medical Care AG & Co. KGaA alternative data
| Aug 2023 | 125,231 |
|---|---|
| Sep 2023 | 124,295 |
| Oct 2023 | 124,295 |
| Nov 2023 | 124,295 |
| Dec 2023 | 123,106 |
| Jan 2024 | 123,106 |
| Feb 2024 | 123,106 |
| Mar 2024 | 119,845 |
| Apr 2024 | 119,845 |
| May 2024 | 119,845 |
| Jun 2024 | 117,128 |
| Jul 2024 | 117,128 |
Fresenius Medical Care AG & Co. KGaA other data
11.24%
-3.17%
of FMS is owned by hedge funds
113
-35
34.41M
-9.71M
shares is hold by hedge funds
| Quarter | Transcript |
|---|---|
| Q1 2024 7 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 20 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 2 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 2 Aug 2023 | Q2 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
Mr. William Valle (1960) Chief Executive Officer of North America Segment & Member of Management Board of Fresenius Medical Care Management AG | $8,250,000 |
Mr. Robert Maurice Powell Jr. (1955) Chairman of the Management Board & Chief Executive Officer of Fresenius Medical Care Management AG | $4,590,000 |
Ms. Helen Giza (1968) Chief Transformation Officer, Chief Financial Officer & Member of Mgmt Board of Fresenius Medical Care Mgmt AG | $2,350,000 |
Dr. Katarzyna Mazur-Hofsab Ph.D. (1963) Chief Executive Officer for EMEA Segment & Member of Management Board of Fresenius Medical Care Management AG | $2,150,000 |
Dr. Franklin W. Maddux F.A.C.P. (1957) Global Chief Medical Officer & Member of Management Board of Fresenius Medical Care Management AG | $2,100,000 |
Ms. Rachel Clare Empey (1976) Member of Supervisory Board of Fresenius Medical Care Management AG | $87,240 |
Fresenius Medical Care: A 'Buy' Going Into 2025
Fresenius Medical Care: Significant Upside Remains
Fresenius Medical Care: What Can We Expect For 2024E
Fresenius Medical Care: Don't Let The Ozempic Kidney Failure Scare You Off
Fresenius SE Probably Found Its Bottom
Fresenius Medical Care: Attractive Post Crash, Maintaining A 'Buy' Rating
Competition Coming For AbbVie's Blockbuster Humira
Fresenius: The Company Is Climbing, And I'm At 'Buy'
Fresenius: A Contrarian Opportunity Not Seen For 20 Years (Technical Analysis)
-
What's the price of Fresenius Medical Care AG & Co. KGaA stock today?
One share of Fresenius Medical Care AG & Co. KGaA stock can currently be purchased for approximately $24.98.
-
When is Fresenius Medical Care AG & Co. KGaA's next earnings date?
Unfortunately, Fresenius Medical Care AG & Co. KGaA's (FMS) next earnings date is currently unknown.
-
Does Fresenius Medical Care AG & Co. KGaA pay dividends?
Yes, Fresenius Medical Care AG & Co. KGaA pays dividends and its trailing 12-month yield is 2.88% with 53% payout ratio. The last Fresenius Medical Care AG & Co. KGaA stock dividend of $0.83 was paid on 7 Jun 2021.
-
How much money does Fresenius Medical Care AG & Co. KGaA make?
Fresenius Medical Care AG & Co. KGaA has a market capitalization of 13.46B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 0.29% to 19.45B US dollars.
-
What is Fresenius Medical Care AG & Co. KGaA's stock symbol?
Fresenius Medical Care AG & Co. KGaA is traded on the NYSE under the ticker symbol "FMS".
-
What is Fresenius Medical Care AG & Co. KGaA's primary industry?
Company operates in the Healthcare sector and Medical - Care Facilities industry.
-
How do i buy shares of Fresenius Medical Care AG & Co. KGaA?
Shares of Fresenius Medical Care AG & Co. KGaA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Fresenius Medical Care AG & Co. KGaA's key executives?
Fresenius Medical Care AG & Co. KGaA's management team includes the following people:
- Mr. William Valle Chief Executive Officer of North America Segment & Member of Management Board of Fresenius Medical Care Management AG(age: 65, pay: $8,250,000)
- Mr. Robert Maurice Powell Jr. Chairman of the Management Board & Chief Executive Officer of Fresenius Medical Care Management AG(age: 70, pay: $4,590,000)
- Ms. Helen Giza Chief Transformation Officer, Chief Financial Officer & Member of Mgmt Board of Fresenius Medical Care Mgmt AG(age: 57, pay: $2,350,000)
- Dr. Katarzyna Mazur-Hofsab Ph.D. Chief Executive Officer for EMEA Segment & Member of Management Board of Fresenius Medical Care Management AG(age: 62, pay: $2,150,000)
- Dr. Franklin W. Maddux F.A.C.P. Global Chief Medical Officer & Member of Management Board of Fresenius Medical Care Management AG(age: 68, pay: $2,100,000)
- Ms. Rachel Clare Empey Member of Supervisory Board of Fresenius Medical Care Management AG(age: 49, pay: $87,240)
-
How many employees does Fresenius Medical Care AG & Co. KGaA have?
As Jul 2024, Fresenius Medical Care AG & Co. KGaA employs 117,128 workers, which is 2% less then previous quarter.
-
When Fresenius Medical Care AG & Co. KGaA went public?
Fresenius Medical Care AG & Co. KGaA is publicly traded company for more then 28 years since IPO on 17 Sep 1996.
-
What is Fresenius Medical Care AG & Co. KGaA's official website?
The official website for Fresenius Medical Care AG & Co. KGaA is freseniusmedicalcare.com.
-
How can i contact Fresenius Medical Care AG & Co. KGaA?
Fresenius Medical Care AG & Co. KGaA can be reached via phone at +49 6172 6082522.
Fresenius Medical Care AG & Co. KGaA company profile:
Fresenius Medical Care AG & Co. KGaA
freseniusmedicalcare.comExchange:
NYSE
Full time employees:
113,079
Industry:
Medical - Care Facilities
Sector:
Healthcare
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Else-KrOener Strasse 1
Bad Homburg, 61352
Bad Homburg, 61352
CIK: 0001333141
ISIN: US3580291066
CUSIP: 358029106
